ZNF692 and nonpapillary renal cell carcinoma: Recent reports have shown that ZNF692 is linked to the recurrence of Wilms’ tumor [12], the prognosis and proliferation of ccRCC [13, 14], and the aggressiveness of lung adenocarcinoma (LUAD) [15] and that it promotes the proliferation and invasion of cervical cancer cells [16].